Mupina (Mupirocin)

Mupirocin, the active ingredient in Mupina, is an antibiotic presented as a topical nasal preparation for intranasal use. It is employed to eradicate nasal carriage of Staphylococcus aureus in patients who are at risk of infection or undergoing procedures where bacterial colonisation could lead to complications.

GNH USA supplies Mupina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is an antibacterial agent used to target colonisation of the nasal passages by Staphylococcus aureus.

- Nasal carriage of Staphylococcus aureus: eradicates colonisation of the nasal mucosa. - Pre‑operative decolonisation: reduces the risk of surgical site infections. - Hemodialysis patients: helps prevent transmission of Staphylococcus aureus. - Healthcare workers with carrier status: eliminates nasal colonisation to limit spread.

Mupirocin is generally well tolerated when applied intranasally, but local and systemic reactions can occur.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Itching: localized pruritus at the application site. - Dryness: dryness of the nasal mucosa. - Sneezing: transient increase in sneezing. - Mild headache: occasional tension‑type headache. - Local erythema: redness of the nasal skin.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe dermatitis: intense inflammation of nasal tissue. - Stevens‑Johnson syndrome: rare mucocutaneous disorder. - Contact urticaria: localized hives upon contact. - Systemic infection: unlikely but reported with extensive use.

Before using Mupina, consider the following safety measures.

- Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a physician. - Allergy: avoid if hypersensitive to mupirocin or formulation excipients. - Duration of therapy: limit to prescribed period to reduce resistance development. - Pediatric use: safety not fully established; use under medical supervision. - Store at room temperature: keep in original container, protect from moisture and heat.

Mupirocin may interact with other agents applied to the nasal area or systemic medications.

Major Interactions (Avoid): - Concurrent use of other topical nasal antibiotics: may increase local irritation and resistance risk. - Nasal corticosteroids combined with mupirocin: could mask signs of infection.

Moderate Interactions (Monitor Closely): - Nasal decongestants: may enhance irritation. - Systemic antibiotics with overlapping spectrum: monitor for additive effects. - Antifungal nasal preparations: assess for combined mucosal effects.